133 related articles for article (PubMed ID: 22673726)
21. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
Radiother Oncol; 2001 Apr; 59(1):65-70. PubMed ID: 11295208
[TBL] [Abstract][Full Text] [Related]
22. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
[TBL] [Abstract][Full Text] [Related]
23. Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
Gulliford SL; Partridge M; Sydes MR; Webb S; Evans PM; Dearnaley DP
Radiother Oncol; 2012 Mar; 102(3):347-51. PubMed ID: 22119373
[TBL] [Abstract][Full Text] [Related]
24. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
25. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
[TBL] [Abstract][Full Text] [Related]
26. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
[TBL] [Abstract][Full Text] [Related]
28. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.
Cambria R; Jereczek-Fossa BA; Cattani F; Garibaldi C; Zerini D; Fodor C; Serafini F; Pedroli G; Orecchia R
Strahlenther Onkol; 2009 Jun; 185(6):384-9. PubMed ID: 19506822
[TBL] [Abstract][Full Text] [Related]
30. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.
Greco C; Mazzetta C; Cattani F; Tosi G; Castiglioni S; Fodor A; Orecchia R
Radiother Oncol; 2003 Nov; 69(2):215-22. PubMed ID: 14643961
[TBL] [Abstract][Full Text] [Related]
31. Effect of various methods for rectum delineation on relative and absolute dose-volume histograms for prostate IMRT treatment planning.
Kusumoto C; Ohira S; Miyazaki M; Ueda Y; Isono M; Teshima T
Med Dosim; 2016; 41(2):136-41. PubMed ID: 26923466
[TBL] [Abstract][Full Text] [Related]
32. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
[TBL] [Abstract][Full Text] [Related]
33. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
34. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?
Teh BS; McGary JE; Dong L; Mai WY; Carpenter LS; Lu HH; Chiu JK; Woo SY; Grant WH; Butler EB
Cancer J; 2002; 8(6):476-83. PubMed ID: 12500857
[TBL] [Abstract][Full Text] [Related]
35. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients.
De Meerleer G; Vakaet L; Meersschout S; Villeirs G; Verbaeys A; Oosterlinck W; De Neve W
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):777-87. PubMed ID: 15465194
[TBL] [Abstract][Full Text] [Related]
37. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
Tucker SL; Cheung R; Dong L; Liu HH; Thames HD; Huang EH; Kuban D; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):353-65. PubMed ID: 15145148
[TBL] [Abstract][Full Text] [Related]
38. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma.
Benk VA; Adams JA; Shipley WU; Urie MM; McManus PL; Efird JT; Willett CG; Goitein M
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):551-7. PubMed ID: 8514551
[TBL] [Abstract][Full Text] [Related]
39. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
[TBL] [Abstract][Full Text] [Related]
40. Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy.
Prabhakar R; Oates R; Daryl J; Chang J; Geso M; Cramb J
J Cancer Res Ther; 2016; 12(1):374-8. PubMed ID: 27072266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
